Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022)

Agios Pharmaceuticals has reported Capital Leases for 4 years, with the latest figure at $276000.0 in Q1 2022.

• For the quarter ending Q1 2022, Capital Leases rose 11.29% year-over-year to $276000.0; the trailing twelve-month figure through Mar 2022 stood at $276000.0 (up 11.29% YoY), and the FY2021 full-year result was $276000.0, down 16.62% from the prior year.
• Capital Leases for Q1 2022 stood at $276000.0, roughly flat from $276000.0 in the prior quarter.
• The five-year high for Capital Leases was $673000.0 in Q4 2019, with the low at $167000.0 in Q2 2021.
• Historically, Capital Leases has averaged $340428.6 across 4 years, with a median of $276000.0 in 2021.
• Annual changes were most pronounced in 2020 — Capital Leases tumbled 50.82% — and 2022, when it gained 11.29%.
• Agios Pharmaceuticals' Capital Leases stood at $673000.0 in 2019, then plunged by 50.82% to $331000.0 in 2020, then declined by 16.62% to $276000.0 in 2021, then changed by 0.0% to $276000.0 in 2022.
• The last three Capital Leases figures came in at $276000.0 (Q1 2022), $276000.0 (Q4 2021), and $167000.0 (Q2 2021), per Business Quant data.